EGFR and neoplasm: A wide variety of receptors, such as transferrin,15 death receptor (DR) complexes,16 epidermal growth factor receptor (EGFR),17 as well as tumor-specific antigens and folate ligands18 have been exploited to selectively target tumor tissues with nanodrugs.